![Jeffrey Buchalter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Buchalter
Amministratore Delegato presso
KBS Healthcare Consulting LLC
Profilo
Jeffrey H.
Buchalter is currently the Chairman & Chief Executive Officer of KBS Healthcare Consulting LLC, Non-Executive Chairman of Archimedes Pharma Ltd., Chairman of CureSearch for Children's Cancer, and Non-Executive Chairman of Inivata Ltd. He previously served as President & Chief Executive Officer of Enzon Pharmaceuticals, Inc., ILEX Oncology, Inc., and Archimedes Pharma Ltd. He was also a Group Director at Wyeth LLC and a Group Vice President at Pharmacia Corp.
Additionally, he has served as a Director at Topotarget A, Symphogen A, Molecular Partners AG, and Tessa Therapeutics Ltd. He holds an MBA from Temple University and an undergraduate degree from Seton Hall University.
Posizioni attive di Jeffrey Buchalter
| Società | Posizione | Inizio |
|---|---|---|
CureSearch for Children's Cancer
 CureSearch for Children's Cancer Miscellaneous Commercial ServicesCommercial Services Dedicates private funds for childhood cancer research for the children's oncology group | Presidente | 15/03/2011 |
Inivata Ltd.
 Inivata Ltd. Packaged SoftwareTechnology Services Develops clinical applications for ctDNA analysis | Presidente | 29/10/2015 |
KBS Healthcare Consulting LLC | Amministratore Delegato | - |
Precedenti posizioni note di Jeffrey Buchalter
| Società | Posizione | Fine |
|---|---|---|
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Direttore/Membro del Consiglio | 03/09/2018 |
| MOLECULAR PARTNERS AG | Direttore/Membro del Consiglio | 18/04/2018 |
Enzon Pharmaceuticals, Inc.
 Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Amministratore Delegato | 22/02/2010 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology Develops drugs to treat and prevent cancer | Presidente | 01/12/2004 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01/01/2000 |
Formazione di Jeffrey Buchalter
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology Develops drugs to treat and prevent cancer | Health Technology |
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Archimedes Pharma Ltd.
 Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic and debilitating illnesses | Health Technology |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
CureSearch for Children's Cancer
CureSearch for Children's Cancer Miscellaneous Commercial ServicesCommercial Services Dedicates private funds for childhood cancer research for the children's oncology group | Commercial Services |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Health Technology |
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Develops clinical applications for ctDNA analysis | Technology Services |
KBS Healthcare Consulting LLC |
